Answers are grounded in this paper and cite their sources.
We report that the amiloride analogues 5-(N,N-hexamethylene)amiloride and 5-(N,N-dimethyl)amiloride inhibit, at micromolar concentrations, the replication of human immunodeficiency virus type 1 (HIV-1) in cultured human blood monocyte-derived macrophages. These compounds also inhibit the in vitro activities of the HIV-1 Vpu protein and might represent lead compounds for a new class of anti-HIV-1 drugs.
No takes yet. Share an insight, caveat, or question.
Ewart et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: